Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment

Ocul Immunol Inflamm. 2018;26(4):518-522. doi: 10.1080/09273948.2017.1298820. Epub 2017 Apr 27.

Abstract

Purpose: To describe a case of bilateral endogenous cryptococcal endophthalmitis in an immunocompetent host and to review adjunctive ophthalmic imaging patterns and treatment.

Methods: A retrospective case report.

Results: A 45-year-old female patient with two distinct presentations of endogenous cryptococcal endophthalmitis in each eye presented initially with progressive blurred vision in the left eye, beginning more than 10 years after a craniotomy with ventriculoperitoneal shunt. Complete ophthalmic imaging was conducted and compared with data from previous literature. Administration of amphotericin-B had poorly responded; however, consolidation of fluconazole resulted in disease stabilization.

Conclusions: Bilateral intraocular cryptococcal infection can present with two distinct patterns of posterior segment findings. A review of ophthalmic imaging patterns found consistency in some characteristics of A-scan ultrasonogram and fundus fluorescein angiogram. Besides conventional treatment, voriconazole is likely to play an important role in the management of cryptococcal endophthalmitis.

Keywords: Cryptococcal infection; endophthalmitis; multimodal imaging.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amphotericin B / administration & dosage
  • Antifungal Agents / administration & dosage
  • Cryptococcosis / diagnosis*
  • Cryptococcosis / drug therapy
  • Cryptococcosis / microbiology
  • Cryptococcus neoformans / isolation & purification*
  • Endophthalmitis / diagnosis*
  • Endophthalmitis / drug therapy
  • Endophthalmitis / microbiology
  • Eye Infections, Fungal / diagnosis*
  • Eye Infections, Fungal / drug therapy
  • Eye Infections, Fungal / microbiology
  • Female
  • Fluorescein Angiography
  • Fundus Oculi
  • Humans
  • Immunocompromised Host*
  • Injections, Intravenous
  • Intravitreal Injections
  • Middle Aged
  • Multimodal Imaging / methods*
  • Ultrasonography

Substances

  • Antifungal Agents
  • Amphotericin B